[Follow-up examination for high risk infants with auditory neuropathy spectrum disorder]

Youhua Wei1, Zhinan Wang, Zhongqiang Xu

  • 1Department of Otorhinolaryngology, Wuhan Children's Hospital, Wuhan, 430012, China. w82828114@163.com

Insights

Auditory neuropathy spectrum disorder (ANSD) in high-risk infants can be temporary. Prognosis is difficult to predict, requiring follow-up until age 3 for accurate diagnosis and management of hearing loss.

Area of Science:

  • Pediatric Audiology
  • Neonatal Screening
  • Auditory Neuropathy Spectrum Disorder (ANSD)

Context:

  • Newborn hearing screening is crucial for early detection of hearing impairments in high-risk infants.
  • Auditory Neuropathy Spectrum Disorder (ANSD) presents unique diagnostic challenges in neonates.
  • Auditory Brainstem Response (ABR) and Otoacoustic Emissions (OAEs) are key audiological assessments.

Purpose:

  • To characterize Auditory Neuropathy Spectrum Disorder (ANSD) in high-risk infants.
  • To evaluate the diagnostic utility of ABR, TEOAE, DPOAE, and CMs in neonates.
  • To understand the transient nature and prognostic indicators of ANSD in this population.

Summary:

  • Eighteen high-risk infants diagnosed with ANSD at 3 months showed absent or elevated ABR thresholds.
  • Follow-up revealed ABR improvement in 9 infants, with hearing loss resolution in 11.
  • Behavioral audiometry indicated a range of hearing loss from mild to profound.

Impact:

  • ANSD in high-risk neonates may exhibit a temporary course, complicating early prognosis.
  • Long-term follow-up (up to 3 years) is essential for accurate diagnosis and management of ANSD.
  • Early identification and monitoring are vital for optimizing developmental outcomes in infants with ANSD.
Abstract

Related Concept Videos